Citrus Glow IPO Valuation: Comparing Three Pricing Models
This paper examines the decision by Citrus Glow to pursue an initial public offering (IPO) and evaluates three competing stock valuation methodologies proposed by company stakeholders. The paper weighs the strategic advantages and disadvantages of going public, then critically assesses the Corporate Value Model (Lisa's approach), a price-ratio comparables method (Dan's approach), and a variable-growth dividend discount model (Joe's approach). Each method is analyzed for its underlying assumptions and practical weaknesses. The paper concludes that no single method is fully reliable as presented, but argues that a adjusted dividend discount model supports a $30 IPO price as a reasonable estimate of fair value.
- IPO Advantages, Disadvantages, and Strategic Context: Weighing capital benefits against control loss and bureaucracy
- Lisa's Corporate Value Model: Present value of future cash flows yields $5.45 per share
- Dan's Price-Ratio Comparables Approach: Competitor ratios produce wide range of valuations
- Joe's Variable Growth Dividend Discount Model: Dividend-based model yields $26.63 per share estimate
- Evaluating and Reconciling the Three Valuations: Critiquing all methods; $30 IPO price as reasonable
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- The paper evaluates each valuation method on its own terms before comparing them, giving each approach a fair hearing before delivering criticism.
- It identifies specific, named flaws in each model—such as the inclusion of depreciation in Lisa's free cash flow and the arbitrary weighting problem in Dan's ratios—rather than offering vague dismissals.
- The conclusion synthesizes the critiques into a practical recommendation ($30 IPO price) anchored to adjusted assumptions, demonstrating applied financial reasoning.
Key academic technique demonstrated
The paper demonstrates comparative critical analysis of quantitative models. Rather than accepting any single valuation framework at face value, it interrogates the assumptions underlying each method—growth rate inputs, dividend appropriateness for a growth firm, and the validity of peer comparables—and uses those critiques to build a reasoned position on fair value.
Structure breakdown
The paper follows a five-part structure: (1) strategic framing of the IPO decision, (2) presentation and critique of the Corporate Value Model, (3) presentation and critique of the comparables approach, (4) presentation and critique of the dividend discount model, and (5) a reconciling conclusion that synthesizes all three valuations into a final price recommendation. Each section builds logically on the previous one.
IPO Advantages, Disadvantages, and Strategic Context
Going public has both advantages and disadvantages. The primary advantage is that it allows a firm to raise a significant amount of capital. The cost, however, is that the company may be required to cede control to investors, and there is a substantial increase in bureaucratic overhead and reporting requirements.
Dan's concerns regarding the IPO are well founded. The company's decision to retain production domestically should be made with respect to a wide range of criteria, including long-term production costs and strategic considerations, and the decision about whether to take the company public must be made within that broader context. At present, the firm has not fully considered this context, nor has it carefully weighed the impact of potentially losing control of the company. Until these factors are incorporated into the decision-making process, the company should not undertake an initial public offering (IPO).
Lisa's Corporate Value Model
The Corporate Value Model (CVM) is based on the theory that rational investors are only willing to pay fair value for an asset, and that fair value is determined as the present value of expected future cash flows. Under the CVM, future cash flows are projected using the firm's historic growth rate. The growth rate over the previous five years averaged 156.75%. The appropriate discount rate is 13.73%. The net capital investment was $2.331 million, and the free cash flow — at least as Lisa calculates it — was $50.042 million. This produces a net present value of $164 million, which over 30 million shares equates to approximately $5.45 per share.
Create your account
Always verify citation format against your institution’s current style guide requirements.